后处理成本约为一个新鲜血浆的处理费用的三分之一，血液来自自愿捐助者。
The cost of reprocessing was about a third of the cost of processing fresh plasma obtained from voluntary donors.
上述结果证明，联合抗过敏新鲜血浆疗法是治疗中晚期EHF行之有效的措施。
The results indicated that combined antiallergic fresh plasma had marked effectiveness in the treatment of EHF at middle and late stages.
结果：患病组的PT和APTT较正常对照组有显著延长，且不能被正常新鲜血浆纠正。
Results: PT and APTT in the patients with fracture were significantly more increased than those in controls, and were not corrected by normal fresh plasma.
应用推荐